Literature DB >> 24202958

Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells.

Lichen Teng1, Yongsheng Chen, Dexin Ding, Hongshuang Dai, Guobin Liu, Changfu Li.   

Abstract

Dendritic cells (DCs) play an important role in anti-renal cell carcinoma (RCC) immunity. The aim of the study was to investigate effect of mimic RCC microenvironment on phenotype and function of DCs. We isolated conditioned media (CM) from supernatants of culturing RCC cells and adjacent non-RCC cells in patients. CD14+ monocytes were obtained from healthy donors. The monocytes derived DCs were treated by RCC CM and non-RCC CM. Maturation markers CD80, CD83, CD86, and HLA-DR on DCs were analyzed using flow cytometry, while the levels of IL-10, TGF-β, and IL12p70 in supernatants were examined by ELISA. The DCs migration treated with RCC CM and non-RCC CM was investigated using transwell assay. The DCs treated and allogenic T cells were co-cultured for detecting T-cell proliferation and change of phenotype on the T cells. Our results indicated that RCC CM inhibited the up-regulation of CD80,CD83, CD86, and HLA-DR in response to LPS in treated DCs and increased IL-10 and TGF-β secretion but reduced IL12p70 production. Moreover, the migration ability of DCs treated with RCC CM was also inhibited, compared to DCs treated with adjacent non-RCC CM. In addition, T-cell proliferation was suppressed in co-culture assay with DCs treated with RCC CM; proportion CD25+Foxp3+ regulatory T cells were induced to increase. This study suggests that RCC CM can inhibit maturation of DCs and impair its function; moreover, DCs treated with RCC CM induce regulatory T cells increase, thus could contribute RCC escape from antitumor immunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24202958     DOI: 10.1007/s11255-013-0595-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

1.  Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.

Authors:  Lichen Teng; Longshan Liu; Yajuan Su; Xiaopeng Yuan; Jun Li; Qian Fu; Siyang Chen; Changxi Wang
Journal:  J Surg Res       Date:  2010-04-15       Impact factor: 2.192

2.  DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors.

Authors:  Joel M Baumgartner; Kimberly R Jordan; Ling-Jia Hu; Cara C Wilson; Anirban Banerjee; Martin D McCarter
Journal:  J Surg Res       Date:  2011-08-24       Impact factor: 2.192

3.  Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8.

Authors:  Esperanza Feijoó; Carlos Alfaro; Guillermo Mazzolini; Patricia Serra; Iván Peñuelas; Ainhoa Arina; Eduardo Huarte; Iñigo Tirapu; Belén Palencia; Oihana Murillo; Juan Ruiz; Bruno Sangro; José A Richter; Jesús Prieto; Ignacio Melero
Journal:  Int J Cancer       Date:  2005-08-20       Impact factor: 7.396

4.  Characterization of the response of dendritic cells and regulatory T cells to tumor antigens in patients with renal cell carcinoma.

Authors:  Ming-Mo Hou; John Wen-Cheng Chang; See-Tong Pang; Yang-Jen Chiang; Yung-Chi Shen; Shuen-Kuei Liao; Jia-Juan Hsieh; Kun-Yun Yeh; Nai-Jen Chang; Cheng-Keng Chuang
Journal:  Chang Gung Med J       Date:  2010 Jan-Feb

5.  Minimal recruitment and activation of dendritic cells within renal cell carcinoma.

Authors:  A J Troy; K L Summers; P J Davidson; C H Atkinson; D N Hart
Journal:  Clin Cancer Res       Date:  1998-03       Impact factor: 12.531

6.  The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy.

Authors:  Niels Halama; Sara Michel; Matthias Kloor; Inka Zoernig; Thora Pommerencke; Magnus von Knebel Doeberitz; Peter Schirmacher; Jürgen Weitz; Niels Grabe; Dirk Jäger
Journal:  Cancer Immun       Date:  2009-02-19

7.  Tumor infiltrating dendritic cells predict treatment response to immmunotherapy in patients with metastatic renal cell carcinoma.

Authors:  Minoru Kobayashi; Kazumi Suzuki; Masahiro Yashi; Masayuki Yuzawa; Norio Takayashiki; Tatsuo Morita
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

8.  Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells.

Authors:  Ivo Marguti; Guilherme Lopes Yamamoto; Thaís Boccia da Costa; Luiz Vicente Rizzo; Luciana Vieira de Moraes
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

9.  Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model.

Authors:  Alexander Kutikov; Brian L Egleston; Daniel Canter; Marc C Smaldone; Yu-Ning Wong; Robert G Uzzo
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

10.  Nephrectomy or nephron-sparing surgery - how to decide?

Authors:  Elżbieta Luczyńska; Sonia Dyczek; Sylwia Heinze-Paluchowska; Artur Komorowski; Tomasz Pawlik; Wojciech Wysocki; Małgorzata Klimek
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15
View more
  7 in total

1.  Clinicopathological significance of galectin-1 expression and percentage of galectin-1-expressing T cells in clear-cell renal cell carcinoma.

Authors:  Yajuan Su; Wentao Wang; Yongpeng Xu; Wei Liangjun; Yanjie Wang; Changfu Li; Lichen Teng
Journal:  Can Urol Assoc J       Date:  2018-03-25       Impact factor: 1.862

Review 2.  The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy.

Authors:  Katrien De Wolf; Karim Vermaelen; Gert De Meerleer; Bart N Lambrecht; Piet Ost
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

3.  Immunosuppressive effect of bladder cancer on function of dendritic cells involving of Jak2/STAT3 pathway.

Authors:  Weigang Xiu; Juan Ma; Ting Lei; Man Zhang; Shangyan Zhou
Journal:  Oncotarget       Date:  2016-09-27

Review 4.  Immune consequences of anti-angiogenic therapyin renal cell carcinoma.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Claudine Kieda
Journal:  Contemp Oncol (Pozn)       Date:  2018-03-05

5.  Endoplasmic Reticulum Stress-Related Signature Predicts Prognosis and Drug Response in Clear Cell Renal Cell Carcinoma.

Authors:  Yuke Zhang; Yancheng Song; Jiangwen Dai; Zhaoxiang Wang; Yuhao Zeng; Feng Chen; Peng Zhang
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988

6.  Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation.

Authors:  Cristina Grange; Marta Tapparo; Stefania Tritta; Maria Chiara Deregibus; Antonino Battaglia; Paolo Gontero; Bruno Frea; Giovanni Camussi
Journal:  BMC Cancer       Date:  2015-12-24       Impact factor: 4.430

Review 7.  Impact of anatomic site on antigen-presenting cells in cancer.

Authors:  Maria Zagorulya; Ellen Duong; Stefani Spranger
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.